David A. Eichenbaum, MD
Show Description +
David Eichenbaum, MD, summarizes his ARVO presentation, which took a retrospective look at a number of pivotal trials in which patients received intravitreal anti-VEGF injections at quarterly intervals. He explains how patients do with this regimen, and talks about being able to detect and predict which patients can tolerate less frequent dosing.
Posted: 5/03/2018
David A. Eichenbaum, MD
David Eichenbaum, MD, summarizes his ARVO presentation, which took a retrospective look at a number of pivotal trials in which patients received intravitreal anti-VEGF injections at quarterly intervals. He explains how patients do with this regimen, and talks about being able to detect and predict which patients can tolerate less frequent dosing.
Posted: 5/03/2018
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARVO: 2018.
Please log in to leave a comment.